Supporting the scientific community

As The Bladder Cancer company, Photocure is actively supporting and undertaking clinical studies

Photocure is actively supporting clinical research in bladder cancer. Building on our knowledge and expertise of the bladder cancer therapy area, we continue to innovate both products and services to ensure better outcomes.

We are partnering with experts in the field to generate new data and support best practice in the care of bladder cancer patients. Our commitment to scientific integrity means we publish all results from clinical trials, positive or negative, and encourage researchers to publish results from the projects we support.

Current, on-going sponsored projects

U.S. Blue Light Cystoscopy with Cysview Registry:

This study, (Clinicaltrials NCT02660645), which has enrolled over 2,700 patients since its inception in 2014, aims to gather valuable information on specific clinical questions in patients with non-muscle invasive bladder cancer (NMIBC). Numerous abstracts, medical presentations, and studies published in peer reviewed journals have been directly produced from this data collection so far.

As the registry continues to enroll patients and add participating locations, Photocure will provide valuable data on the management and treatment of NMIBC to produce further research and publications in this field.

Other supported projects

Our mission is to deliver transformative solutions to improve the lives of bladder cancer patients. We continue to support research that further advance the diagnosis, detection, and management of bladder cancer. Currently, we support several investigator initiated trials, both in Europe and in the U.S.

Our general area of interest is focused around management of non-muscle invasive bladder cancer. We welcome your application for research support within this field. Please provide details of your project for assessment by our Medical team.

News and events